Back to Search
Start Over
Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion.
- Source :
-
Pathology, research and practice [Pathol Res Pract] 2022 May; Vol. 233, pp. 153878. Date of Electronic Publication: 2022 Apr 04. - Publication Year :
- 2022
-
Abstract
- Plexiform fibromyxoma (PFM) is a rare gastrointestinal tract tumor that develops in the stomach in most cases. Here, we report an extremely rare case of esophageal PFM. A female in her mid-30 s presented with difficulty in swallowing and breathing. Endoscopic examination revealed a submucosal tumor measuring approximately 45 × 50 mm in the upper thoracic esophagus. The biopsied specimen did not show definite histological evidence of gastrointestinal stromal tumors (GISTs). Since imatinib administration based on a clinical diagnosis of GIST did not show a therapeutic effect for tumor reduction, tumor resection was performed. The resected tumor exhibited proliferation of spindle tumor cells with abundant myxoid and vascular stroma separated by a muscular layer, indicating a plexiform arrangement. Immunohistochemical analysis demonstrated that the tumor cells diffusely expressed vimentin and alpha-smooth muscle actin, but not desmin, c-kit, DOG1, and CD34. MALAT1-GLI1 fusion was detected in formalin-fixed paraffin-embedded tissue using RT-PCR and Sanger sequencing. The results suggested that a fibromyxoid tumor can develop in the esophagus, showing an identical histology and MALAT1-GLI1 fusion to gastric PFM.<br /> (Copyright © 2022 Elsevier GmbH. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1618-0631
- Volume :
- 233
- Database :
- MEDLINE
- Journal :
- Pathology, research and practice
- Publication Type :
- Academic Journal
- Accession number :
- 35397317
- Full Text :
- https://doi.org/10.1016/j.prp.2022.153878